Mezzanotte, V.; Paterno, G.; Cerroni, I.; De Marchi, L.; Taka, K.; Buzzatti, E.; Mallegni, F.; Meddi, E.; Moretti, F.; Buccisano, F.;
et al. Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response. J. Clin. Med. 2025, 14, 1254.
https://doi.org/10.3390/jcm14041254
AMA Style
Mezzanotte V, Paterno G, Cerroni I, De Marchi L, Taka K, Buzzatti E, Mallegni F, Meddi E, Moretti F, Buccisano F,
et al. Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response. Journal of Clinical Medicine. 2025; 14(4):1254.
https://doi.org/10.3390/jcm14041254
Chicago/Turabian Style
Mezzanotte, Valeria, Giovangiacinto Paterno, Ilaria Cerroni, Lucrezia De Marchi, Kristian Taka, Elisa Buzzatti, Flavia Mallegni, Elisa Meddi, Federico Moretti, Francesco Buccisano,
and et al. 2025. "Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response" Journal of Clinical Medicine 14, no. 4: 1254.
https://doi.org/10.3390/jcm14041254
APA Style
Mezzanotte, V., Paterno, G., Cerroni, I., De Marchi, L., Taka, K., Buzzatti, E., Mallegni, F., Meddi, E., Moretti, F., Buccisano, F., Maurillo, L., Palmieri, R., Gurnari, C., Venditti, A., & Del Principe, M. I.
(2025). Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response. Journal of Clinical Medicine, 14(4), 1254.
https://doi.org/10.3390/jcm14041254
